Showing results (11-20 of 181) with videos related to
Sort By:
Pageof 19
Future Virology|January 3, 2012
Exploring kinase inhibitors as therapies for human arenavirus infectionsEric M Vela, Gavin C Bowick, Norbert K Herzog, et al.The Journal of General Virology|January 26, 2007
African swine fever virus A238L inhibitor of NF-kappaB and of calcineurin phosphatase is imported actively into the nucleus and exported by a CRM1-mediated pathwayRhiannon N Silk, Gavin C Bowick, Charles C Abrams, et al.Annual Review of Entomology|August 18, 2006
Yellow fever: a disease that has yet to be conqueredAlan D T Barrett, Stephen HiggsVirology|August 28, 2007
Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virusGregory D Gromowski, Alan D T BarrettCell Host & Microbe|May 15, 2020
Finding Their Type: Elusive Antigenic Sites on Dengue Virus 3 Mapped with Human AntibodiesVanessa V Sarathy, Alan D T BarrettNature Reviews. Microbiology|September 21, 2004
Transmission cycles, host range, evolution and emergence of arboviral diseaseScott C Weaver, Alan D T BarrettFEMS Immunology and Medical Microbiology|November 20, 2003
Comparative phylogenies of yellow fever isolates from Peru and BrazilJuliet E Bryant, Alan D T BarrettVaccines|July 2, 2021
Flavivirus NS1 and Its Potential in Vaccine DevelopmentKassandra L Carpio, Alan D T BarrettPharmaceuticals (Basel, Switzerland)|September 28, 2021
The Present and Future of Yellow Fever VaccinesClairissa A Hansen, Alan D T BarrettExpert Review of Vaccines|September 15, 2015
Current status and future prospects of yellow fever vaccinesAndrew S Beck, Alan D T BarrettPageof 19